Recent News

• 08.06.2025 - Q2 2025 Procept BioRobotics Earnings Conference Call
• 08.06.2025 - PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
• 07.24.2025 - PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
• 07.23.2025 - Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
• 07.21.2025 - PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
• 07.15.2025 - Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
• 06.17.2025 - 2025 Truist Med-Tech Conference

Recent Filings

• 08.06.2025 - 8-K Current report
• 08.06.2025 - EX-99.1 EX-99.1
• 07.25.2025 - EX-99.1 EX-99.1
• 07.25.2025 - 8-K Current report
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.12.2025 - 4 Statement of changes in beneficial ownership of securities